How We Gave an Angel Group and a Diagnostics Founder the Same Confidence in Its IP with the IPRSCORE™

How We Gave an Angel Group and a Diagnostics Founder the Same Confidence in Its IP with the IPRSCORE™

Lab technician in blue gloves drawing a sample from a vial

$5m

$5m

angel round closed

angel round closed

1 week

1 week

to complete the IPRSCORE™

to complete the IPRSCORE™

3 years

3 years

of IP development independently validated

of IP development independently validated

Case Studies

>

Medical Diagnostics Company

Industry

Diagnostics

Audience

Investor

The Challenge

An early-revenue medical diagnostics business was raising angel funding for growth, with much of its value resting in its IP portfolio. The angel group had already used IPRSCORE™ for earlier portfolio analysis and insisted on a score as part of its due diligence on this new investment.

What IPRSCORE™ Revealed

Introduced to IPRSCORE™ by the angels, the company had its score completed within a week. It provided independent evidence of strong IP capable of supporting the scale-up business plan. Management also gained valuable outside feedback on the strength of the IP they had been building over the previous three years.

The Outcome

With validation for both investors and Management, the company closed a successful $5m investment round.

The Takeaway

IPRSCORE™ gave the angel group a unique benchmark for the new investment and a fresh IP lens for assessing the rest of its portfolio companies.

Curious how this would look in your situation? Talk to us.

© Metis Partners Inc.

© Metis Partners Inc.